CLINICAL SCIENCES. Conclusions: A distinctive postbrachytherapy regression

Similar documents
Retina Center of Oklahoma Sam S. Dahr, M.D. Adult Intraocular Tumors

Characteristic Ultrasonographic Findings of Choroidal Tumors

Outline. Brief history and principles of ophthalmic ultrasound. Types of ocular ultrasound. Examination techniques. Types of Ultrasound

Dosimetric Benefit of a New Ophthalmic Radiation Plaque

Vitreoretinal surgical management In ocular oncology

Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (CSC)

Transvitreal Fine Needle Aspiration Biopsy of Choroidal Melanoma via Pars Plana Vitrectomy

CLINICAL SCIENCES. Three-Dimensional Ultrasound for the Measurement of Choroidal Melanomas

Case Study. Monocular Malignant Melanoma

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 55/ July 09, 2015 Page 9665

We report the absence of photic retinal injury after exposing the retina to light from

Case Rep Oncol 2012;5: DOI: /

Gene Expression Profiling has been proposed as a method of risk stratification for uveal melanoma.

Financial Disclosures. The Eye in Neoplastic Disease. Course Goal. We wish to acknowledge and thank: Tumor Definition

Metastasis of choroidal melanoma to the contralateral

Ultrasound biomicroscopy: role in diagnosis and management in 130 consecutive patients evaluated for anterior segment tumours

M alignant melanoma of the uvea causes clinical metastases

Cyberknife Radiosurgery for Uveal Melanoma

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Seed coordinates of a new COMS-like 24 mm plaque verified using the FARO Edge

DIAGNOSTIC TRANSVITREAL FINE-NEEDLE ASPIRATION BIOPSY OF SMALL MELANOCYTIC CHOROIDAL TUMORS IN NEVUS VERSUS MELANOMA CATEGORY

Optical coherence tomography findings in a child with posterior scleritis

Systemic and ocular follow-up after conservative management of an intraocular tumor

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation

CLINICAL PEARLS IN OCULAR ONCOLOGY

High-Frequency Ultrasound Characteristics of 24 Iris and Iridociliary Melanomas

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

M ALIGNANT MELANOMA OF THE UVEA STAGING FORM

Ruthenium-106 plaque brachytherapy in the primary management of ocular medulloepithelioma

Uveal Melanoma. Protocol applies to malignant melanoma of the uvea.

A Patient s Guide to Diabetic Retinopathy

Tall, dark and.. Uh oh

A study of iris melanoma in Northern Ireland

Ocular Neoplasia What s Common? What s New? Richard R Dubielzig

Financial Disclosures

Mesectodermal suprauveal iridociliary leiomyoma: Transscleral excision without postoperative iris defect

A REANALYSIS OF THE COLLABORATIVE OCULAR MELANOMA STUDY MEDIUM TUMOR TRIAL EYE PLAQUE DOSIMETRY

TABLES. Table 1: Imaging. Congress of Neurological Surgeons Author (Year) Description of Study Classification Process / Evidence Class

Factory loaded, sterilized, ready to implant plaques:!

Can Protons replace Eye Brachytherapy? 1 Department of Radiation Oncology

Research Article Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience

B-Scon. T4vI55)SOi}i)ii5 IFIG. I Schematic diagram comparing A- and B- scan ocular ultrasonograms. The B-scan is an

Proton Radiation Therapy of Ocular Melanoma at PSI

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

UCSF Uveal Melanoma Program: Outcomes with Proton Beam Radiation Therapy Kavita K. Mishra, M.D., M.P.H. UCSF Comprehensive Cancer Center

COMMUNICATIONS PHOTOCOAGULATION OF THE RETINA* OPHTHALMOSCOPIC AND HISTOLOGICAL FINDINGS. photocoagulation of the rabbit's retina.

Pseudohypopyon in Retinoblastoma. Choroidal Nevus. Masquerade Syndromes. Vision pathways. Flat with uniform color

Quantitative Evaluation of Sunset Glow Fundus in Vogt Koyanagi Harada Disease

Outcomes Following Negative Prostate Biopsy for Patients with Persistent Disease after Radiotherapy for Prostate Cancer

Masquerade Scleritis CASE REPORT INTRODUCTION

Advances in Ocular Imaging

Photocoagulation of disciform macular lesions

Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage

Autoimmune retinopathy associated with colonic adeno. The original publication is available at Instructions for use

Haemorrhagic glaucoma

VERTEPORFIN IN PHOTODYNAMIC THERAPY STUDY GROUP

Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why?

Asadi-Amoli et al Adenocarcinoma of RPE Iranian Journal of Ophthalmology - Volume 19, Number 4, 2007

Detecting ultrasonographic hollowness in small choroidal melanocytic tumors using 10 MHz and 20 MHz ultrasonography: a comparative study

Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma

Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan

Visual prognosis after panretinal photocoagulation for. Proliferative diabetic retinopathy (PDR)

number Done by Corrected by Doctor Maha Shomaf

surgery Macular puckers after retinal detachment and loss of the macular reflex with a greyish appearance of the macula

IN MANY DEVELOPED COUNTRIES, A

CLINICAL SCIENCES. Symptoms and Findings Predictive for the Development of New Retinal Breaks

EXPERIMENTAL THERMAL BURNS I. A study of the immediate and delayed histopathological changes of the skin.

Fluorescein and Indocyanine Green Videoangiography of Choroidal Melanomas

Anterior segment imaging

OCULAR FINDINGS IN HAEMOCHROMATOSIS*

Long-Term Survivors with Metastatic Uveal Melanoma

C ancer cells require a great deal of sugar (glucose) for. PET/CT imaging: detection of choroidal melanoma SCIENTIFIC REPORT

Sonography of the Eye

Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy?

Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD

CLINICAL SCIENCES. Pretreatment Characteristics and Response to Plaque Radiation Therapy

An Interactive TreatmentPlanning System For Ophthalmic Plaque Radiotherapy

Endoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy

HORMONE THERAPY OF MALE BREAST HYPERTROPHY

HYPERPLASIA OF THE ANTERIOR LAYER OF THE IRIS STROMA*t

Continuing Medical Education

Bilateral retinoblastoma in early infancy

Coagulative necrosis in a malignant melanoma of the choroid at the macula with extensive subretinal hemorrhage

Platelet-induced vitreous membrane formation*

5-S-Cysteinyldopa as Diagnostic Tumor Marker for Uveal Malignant Melanoma

Multimodal imaging of retinal metastasis masquerading as an acute retinal necrosis

MELANOMA OF THE CHOROID EXAMINED WITH AN ACOUSTIC BIOMICROSCOPE*

CLINICAL SCIENCES. Histopathologic Findings in Eyes With Retinoblastoma Treated Only With Chemoreduction

ADVANCED DIAGNOSTIC TECHNIQUES

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Moncef Khairallah, MD

PLEOMORPHIC ADENOMA ( BENIGN MIXED TUMOR )

PanMidlands Ocular Cancer Pathway March 2008 Approved by The Midland Oculoplastic Surgery Society

Quantitative OCT Angiography Evaluation of Peripapillary Retinal Circulation after Plaque Brachytherapy

Ruthenium-106 Plaque Radiotherapy for Retinal Vasoproliferative Tumors

Benign melanoma of the choroid

APOCRINE SWEAT GLAND CARCINOMA OF THE VULVA* JOHN R. McDONALD, M.D. Section on Surgical Pathology, The Mayo Clinic, Rochester, Minnesota

Complicated Cataract to Intraocular Tumors, Beware of the unexpected

We report the case of a 77-year-old woman in whom choroidal metastasis was the

Transcription:

horoidal Melanomas With a ollar-utton onfiguration Response Pattern fter Iodine 125 rachytherapy Dennis M. Robertson, MD LINIL SIENES Objective: To describe a distinctive type of postbrachytherapy response pattern among choroidal melanomas with a collar-button configuration. Methods: Ninety-three consecutive eyes with choroidal melanoma treated with iodine I 125 brachytherapy before 1991 were reviewed to identify melanomas with a collar-button configuration. Postbrachytherapy response patterns of these melanomas were reviewed. Results: Thirty-four of the 93 eyes contained tumors with a collar-button configuration. Sixteen (47%) of the 34 eyes demonstrated a postbrachytherapy response pattern characterized by persistence of the collar-button, while the body of the tumor demonstrated shrinkage. During followup, the color of the collar-button configuration changed from light brown to dark chocolate (16 [47%] of 34 eyes). Subsequently, irregularly clumped, darkly pigmented debris was observed to slough from the surface of the collarbutton configuration into the vitreous cavity (7 [21%] of 34 eyes). The debris was comprised largely of pigmentladen macrophages in 1 eye in which a vitrectomy was performed. In another eye, histopathologic study of spherical clusters of intravitreal brown-colored debris identified malignant melanoma cells. onclusions: distinctive postbrachytherapy regression pattern of melanoma with a collar-button configuration has been identified. The main body of the tumor shrinks, whereas the collar-button configuration persists, appears more prominent, gradually changes to a darker color, and may then shed pigmented debris into the vitreous cavity. This pigmented debris may be composed of pigment-laden macrophages and/or melanoma cells. linical characteristics of the vitreous debris may help distinguish malignant invasion by melanoma cells from infiltration by nonmalignant debris and macrophages. rch Ophthalmol. 1999;117:771-775 From the Department of Ophthalmology, Mayo linic, Rochester, Minn. RHYTHERPY is an accepted treatment for selected choroidal melanomas. While there have been many publications 1-3 discussing tumor control, visual results, and mortality rates following radiation treatment, there has been little written about the details of response patterns following radiation treatment. During the past 2 decades, a distinctive type of response pattern that may be seen after brachytherapy of choroidal melanomas with collar-button configuration has been recognized. This report describes this distinctive response pattern and discusses the clinical implications. RESULTS The medical records of 93 patients with a clinical diagnosis of choroidal malignant melanoma treated with 125 I brachytherapy were reviewed. Thirty-four of the patients had melanomas with a collar-button configuration. The age of the patients ranged from 26 to 84 years (mean, 60 years). Twenty-one right eyes and 13 left eyes were affected. Tumor sizes ranged from 3.0 to 8.0 mm in thickness (measured from the tumor base to the apex of the collar-button configuration). The smallest base dimension measured 5.0 6.5 mm. The base dimension of the largest tumor was 15.0 18.0 mm. Follow-up ranged from 1 to 16 years. Following brachytherapy, tumors in 4 eyes grew and the eyes were enucleated (2 of the eyes were enucleated because of treatment failures within the first year, and 2 other eyes were enucleated at 5 and 7 years when the tumors demonstrated an increase in thickness). Fifteen eyes had a uniform shrinkage of the tumor during follow-up. Sixteen (47%) of the 34 eyes showed a distinctive posttreatment response pat- 771

MTERILS ND METHODS The medical records of 93 consecutive patients managed with iodine 125 ( 125 I) brachytherapy for malignant melanoma at the Mayo linic, Rochester, Minn, by me (D.M.R.) from 1973 to 1991 were reviewed. Those identified as having collar-button configurations either by ophthalmoscopy or ultrasonography were the subject of this review. The age, sex, laterality of the tumor, base dimension, thickness, and response following brachytherapy were recorded. Tumor thickness was determined from the tumor base to the tumor apex. In this series, the tumor apex was always the apex of the collar-button configuration. ll tumors were treated with a prescription dose of 100 Gy to the apex of the tumor. Photographic and ultrasonographic findings were retrospectively reviewed. Medical records were reviewed to determine the status of the patient at follow-up. None of the patients included in this review were participants in the ollaborative Ocular Melanoma Study. tern that was characterized by persistence of the collarbutton prominence, while the main body of the tumor showed evidence of shrinkage. lthough the height of the tumors decreased as measured from the base to the apex of the collar-button configuration, the decreasing mass of the tumor body made the collar-button appear more prominent. During an interval of 1 1 2 to 7 years, the color of the collar-button prominence tended to change from a light milk chocolate to a darker chocolate (16 [47%] of 34 eyes) (Figure 1 and Figure 2). When the darker chocolate color appeared, the texture of the tumor surface appeared similar to velvet. Once this stage was seen, the tumor remained relatively unchanged (7 [21%] of 34 eyes); the tumor began to shed pigmented debris into the vitreous cavity (7 [21%] of 34 eyes); or the collar-button prominence silently regressed, leaving a central umbilication in the tumor (2 [6%] of 34 eyes) (Table 1 and Table 2). In the 7 eyes in which pigmented debris was shed into the vitreous cavity, the debris emanated from the dark, velvety surface of the collar-button prominence. The average duration from the time of brachytherapy until the time pigmented debris began to discharge into the vitreous cavity was almost 6 years. The pigmented debris was often dense enough that it could easily be demonstrated ultrasonographically (Figure 2, D, and Figure 3, ); sometimes the debris was so extensive that it obscured the fundus details (Figure 3, D). The pigmented debris was identified as pigment-laden macrophages from a vitrectomy specimen in 1 eye (case 7, Table 1 and Figure 3, E); in this eye, the debris was irregularly clumped throughout the vitreous without any tendency to cluster into spherules. lthough the debris appeared almost black when viewed with indirect ophthalmoscopy and when photographed with the fundus camera (Figure 3, D), individual particles often appeared dark gold or rust colored with slitlamp biomicroscopy. In another eye, histopathologic study of the vitreous confirmed the presence of malignant melanoma cells within the pigmented debris; in this eye, the pigmented debris continued to shed from the collar-button configuration for 2 1 2 years before the debris began to cluster into brown spherules in the vitreous cavity, having an appearance reminiscent of planets orbiting in space. This eye was enucleated 7 1 2 years after brachytherapy (case 4, Table 1). The details of this case have been previously published. 4 In 2 additional eyes followed up for 11 and 16 years, there was a slowly progressive disappearance of the collar-button prominence, eventually resulting in a central umbilication of the tumor (Figure 4). This occurred without recognizable discharge of tumor debris into the vitreous cavity. In these 2 cases, the remaining tumor surrounding the umbilication was the only portion of the tumor that could be discerned with ultrasonography. Thirteen of the 34 patients died during follow-up, which ranged from 1 to 16 years. The cause of death was from presumed melanoma metastasis in 5 patients, other known causes in 5 patients, and unknown causes in 3 patients. Of the 7 patients in whom the postbrachy- Figure 1. ase 1., ollar-button configuration of a choroidal melanoma., ollar-button has assumed a dark chocolate color while most of the main body of the tumor has shown evidence of shrinkage. 772

D Figure 2. ase 2., Three collar-button excrescences on a choroidal tumor before brachytherapy., Four years after brachytherapy, 2 of the collar-button lesions have assumed the dark chocolate color., ll 3 collar-button configurations have developed a dark chocolate color, and pigmented debris is being shed into the vitreous cavity. D, -scan ultrasonographic study demonstrating pigmented debris arising from the surface of the tumor. Table 1. Melanomas With ollar-utton onfiguration (34 Eyes) and ollar-uttons Developing Dark hocolate ppearance With Shedding of Pigmented Debris Into the Vitreous avity (7 Eyes) ase No. Pretreatment Height, mm Posttreatment Height When Pigment Shedding Seen, mm Interval etween Treatment (rachytherapy) and Intravitreal Pigment Shedding, y 1 7.0 4.9 7 2 7.0 5.4 10 3* 5.5 4.2 6 4 4.5 5.4 5 5 6.9 2.4 8 6 4.7 3.7 3 7 7.1 3.9 1.5 *See Figure 2. Seven and a half years after brachytherapy, the tumor grew and the eye was enucleated; tumor cells were identified within vitreous cavity. 4 See Figure 3. Table 2. Melanomas With ollar-utton onfiguration (34 Eyes) and ollar-uttons Developing Dark hocolate ppearance Without Shedding of Pigmented Debris Into the Vitreous avity (9 Eyes) ase No. Pretreatment Height, mm Posttreatment Height When hocolate olor Developed, mm Interval etween Treatment (rachytherapy) and Development of hocolate olor, y 8 6.9 3.4 4 9 8.0 3.0 1.50 10* 8.0 3.9 5 11 4.0 1.9 3 12 6.4 3.2 3 13 5.9 3.2 2 14 5.0 4.2 5 15 3.5 1.5 6 16 3.0 1.0 3 *See Figure 1. ollar-buttons regressed into an umbilicated depression 11 years (case 15) and 16 years (case 16) after brachytherapy. The rim of the tumor in each case was the only portion of the tumor discernible with ultrasonography. See Figure 4. therapy response pattern included the discharge of irregularly clumped, darkly pigmented debris into the vitreous cavity, 1 died of lung cancer 10 years after brachytherapy; 2 died of metastatic melanoma 3 and 7 years after brachytherapy; and 4 are alive and well 6, 7, 8, and 12 years following brachytherapy. OMMENT mong choroidal melanomas with a collar-button configuration, there appears to be a common and rather distinctive regression pattern following 125 I brachytherapy. In this pattern, the main body of the tumor 773

D E F 10 µm 10 µm Figure 3. ase 3., Melanoma with a collar-button configuration before brachytherapy., ollar-button has developed a dark chocolate color; intravitreal pigmented debris could be seen arising from the surface of the collar-button., Ultrasonographic study showing the presence of debris in the vitreous cavity arising from the collar-button surface. D, Fundus photograph demonstrating the extensive intravitreal pigmented debris causing obscuration of fundus details. Radiation retinopathy is evident. E, Vitrectomy specimen demonstrating the presence of a pigment-laden macrophage (osmium tetroxide and en bloc uranyl acetate, magnification 4600). F, Vitrectomy specimen showing pigment granules within the cytoplasm of a macrophage (osmium tetroxide and en bloc uranyl acetate, magnification 56 000). responds to radiation treatment by shrinking, whereas the collar-button configuration persists and appears to become more prominent. lthough the main body of the tumor appears to shrink more than the collarbutton configuration, 3-dimensional studies were not available to document this apparent differential shrinkage. During an interval of 1 1 2 to 7 years, the color of the collar-button configuration then tends to change from light brown to dark milk chocolate (Figures 1 and 2). oincident with the color change, the surface of the collar-button configuration often develops a texture reminiscent of velvet. Once this stage is reached, 1 of 2 changes may be observed. The collar-button configuration may slowly atrophy, resulting in a central umbilication within the tumor (in the absence of recognized shedding of debris into the vitreous cavity [Figure 4]), or the collar-button surface may begin to discharge large amounts of pigmented debris into the vitreous cavity (Figures 2 and 3). The debris tends to be almost black, as seen with indirect ophthalmoscopy and as recorded with fundus photography (Figure 3, D). Slitlamp biomicroscopy usually allows the examiner to identify that some of the debris is dark gold or rust colored. In most instances, the debris is irregularly clumped. I believe that intravitreal debris with this type of appearance is generally benign and is composed of 774

Figure 4. ase 4., horoidal tumor with collar-button formation in a 42-year-old woman before brachytherapy (3.5 mm thickness)., ollar-button tumor is now visible with a prominent chocolate appearance 7 years after brachytherapy., Eleven years after brachytherapy, the central portion of the tumor has become umbilicated as the collar-button prominence has atrophied. The remainder of the tumor is less than 1 mm thick. necrotic tissue and pigment granules, some of which have been ingested by macrophages. Such a benign cellular reaction was confirmed in 1 eye (case 7) that underwent vitrectomy to improve vision (Figure 3, E and F). In contrast, if the pigmented debris becomes clustered into spherules within the vitreous cavity, particularly if these spherules are brownish, malignant invasion can be suspected. Histopathologic study confirmed that the intravitreal light brown spherules seen following brachytherapy of a choroidal melanoma in 1 of these cases were indeed composed of malignant melanoma cells (case 4). In the latter case, the spherical clusters in the vitreous were believed to represent malignant invasion, and the eye was enucleated. Examination of the enucleated eye confirmed the presence of malignant cells in the vitreous cavity. Details of this latter case have been reported. 4 In 2 eyes, the collar-button excrescence that developed a dark chocolate color eventually atrophied, leaving a central umbilication. In neither of these eyes was pigmented debris seen shedding into the vitreous cavity. Presumably the necrotic collar-button configuration was phagocytosed by surrounding tissue; alternately, continued shedding of the debris into the vitreous cavity was too subtle to be recognized clinically. I believe that the presence of irregularly clumped pigmented intravitreal debris arising from the surface of a melanoma after brachytherapy is not an indication for additional therapy since the debris most likely represents nonmalignant infiltration by pigment and pigment-laden macrophages. If the debris becomes dense enough to impair the patient s vision, a vitrectomy may be considered. However, if the debris is clustered into brownish spherules that become suspended throughout the vitreous cavity, reminiscent of the appearance of planets in space, malignant invasion should be suspected. Further follow-up of these and other similar cases will be necessary to learn whether the shedding of pigmented debris into the vitreous cavity has any implications relating to survival. The cases in this small series are too few to draw any conclusions regarding prognosis. Of the 7 patients in whom the postbrachytherapy response pattern included the discharge of pigmented debris into the vitreous cavity, 1 died of lung cancer 10 years after brachytherapy; 2 died of metastatic melanoma 3 and 7 years after brachytherapy; and 4 are alive and well 6, 7, 8, and 12 years following brachytherapy. ccepted for publication December 26, 1998. Supported in part by a grant from Research to Prevent lindness Inc, New York, NY. Reprints: Dennis M. Robertson, MD, Department of Ophthalmology, Mayo linic, Rochester, MN 55905. REFERENES 1. Robertson DM, Earle J, Kline RW. rachytherapy for choroidal melanoma. In: Ryan SJ, ed. Retina. 2nd ed. St Louis, Mo: Mosby Year ook Inc; 1994:772-784. 2. Wilkes SR, Gragoudas ES. Regression patterns of uveal melanomas after proton beam irradiation. Ophthalmology. 1982;89:840-844. 3. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997; 42:215-223. 4. Robertson DM, ampbell RJ. Intravitreal invasion of malignant cells from choroidal melanoma after brachytherapy. rch Ophthalmol. 1997;115:793-795. 775